IEEE ICDH 2023 Symposium on Global Digital Health

We are delighted to welcome you to the upcoming IEEE International Symposium on Global Digital Health, a prestigious event designed to ignite discussions, inspire innovations, and foster collaborations in the ever-evolving digital health landscape. This symposium is an exceptional opportunity for esteemed industry leaders, academic experts, and policy makers to come together and share their knowledge, experiences, and visions for the future of digital health on a global scale.

In our interconnected world, the importance of equitable access to high-quality healthcare has never been more critical. This year’s focus areas may include Health Equity, Foundational Technologies for Digital Health, and highlighting NIH/NSF funded projects. These discussions will delve into the transformative potential of digital health technologies.

The IEEE International Symposium on Global Digital Health is poised to be an enlightening and inspiring event for all those committed to shaping the future of healthcare. We eagerly anticipate your participation and valuable contributions to this paramount discussion. Let us work together to redefine global digital health and create a better future for all.


Date/Time Session Presentation
Wednesday 7/5
14:00 - 15:10
Location: Comiskey
Keynote: What is Next in Digital Health? Is There Still Space for Innovation?
Wendy Nilsen, NSF

NSF Student Project Presentations
Wednesday 7/5
15:25 - 16:35
Location: Comiskey
Panel Discussion: Health Equity
Panel Chair: Bo Wen, IBM Research
Panel Moderator: Thaddeus Steppenbeck, Cleveland Clinic
John G. Dinsmore, Trinity College Dublin
Julia Liu, Morehouse School of Medicine
Guillermo Cecchi, IBM Research
Wednesday 7/4
16:50 - 18:00
Location: Comiskeyt
Panel Discussion: Close-Loop Therapy and Treatment
Panel Chair & Moderator: Jeffrey L. Rogers, IBM Global Research Leader for Digital Health
Matt McDonald, Boston Scientific
Joshua Rosenow, Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital
Douglas J. Weber, Carnegie Mellon University

ICDH 2023 Distinguished Speaker

What is Next in Digital Health? Is there Still Space for Innovation?
Wendy Nilsen, NSF

Wendy Nilsen, Ph.D. is the Acting Deputy Division Director in the Information and Intelligent Systems Division of the Computer and Information Science and Engineering Directorate at NSF. She is also the lead Program Director in the NSF-NIH joint initiative Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science program. Her work has focused on the intersection of computing and human functioning. Her interests span the areas of sensing, analytics, cyber-physical systems, information systems, machine learning, artificial intelligence and robotics. She also serves as cochair of the Health Information Technology Research and Development working group of the Networking and Information Technology Research and Development Program and, serving on numerous federal technology initiatives. Prior to joining NSF, Wendy was at the National Institutes of Health.

Session 2: Panel Discusson on Health Equity
July 5, 15:25 - 16:35
Location: Comiskey

Potential discussion topics:
- Expanding access to high-quality healthcare in rural areas using digital health technology: IoT, wearables, and connected devices enabling remote monitoring and care by medical professionals.
- Exploring public health policies to address health equity and promote equal access to healthcare resources.
- Early interventions for advanced diseases, such as high blood pressure and cardiovascular disease, with a focus on providing affordable care for lower-income populations to reduce the long-term societal and family burden.
- Addressing the issue of democratization of health information, including disease and treatment information as well as 'healthcare navigation' help.
- Discussing a digital health interventional approach to provide equitable, affordable, and quality healthcare for individuals managing multiple chronic health condition.

Panel Chair: Bo Wen, IBM Research, is a versatile researcher with extensive expertise in scientific experiment design and execution, data orchestration and analysis, semiconductor/electronics/software development, and cloud architect. He has a keen interest in digital health, cognitive science, and physics. In his leisure time, he studies the influence of neuroscience and information theory on the scientific discovery process.

Panel Moderator: Thaddeus Steppenbeck, Cleveland Clinic, received his B.A as a member of the Integrated Science Program at Northwestern University, as well as his M.D and Ph.D. from Northwestern University Medical School. He trained in anatomic pathology at the Washington University School of Medicine. He was hired as an assistant Professor in the Department of Pathology and Immunology at Washington University, where he moved up the ranks to Division Chief of Laboratory and Genomic Medicine. Dr. Stappenbeck currently serves as the chair of Inflammation and Immunity at Cleveland Clinic, where his research program focuses on determining the root causes of inflammatory and infectious diseases with the goal of developing new therapies for these diseases. His lab has defined stages and mechanisms of intestinal repair leading to a lead compound for a novel therapy for inflammatory bowel disease and idiopathic pulmonary fibrosis, determined mechanisms for the effects of intestinal microbes on repair and created a cell culture system for human intestinal stem cells that is used by labs around the world. He moved to Cleveland Clinic to partner with the world class clinicians and scientists in this institution to accelerate the translation of discoveries in immunology, developmental biology, cell biology, and microbiology to new concepts for therapy in inflammatory disease. He serves on scientific advisory boards for Science Immunology, as well as several companies in the area of inflammatory bowel diseases. He is a member of ASCI/APP. He has collaborated extensively with many other investigators and published over 170 articles in high impact journals, while successfully training numerous physician-scientists and scientists and encouraging them to inflammatory and infectious disease. His lab has been supported by broad portfolio including the National Institute of Health, Crohn’s Colitis Foundation of America, Helmsley Trust, American Asthma Foundation, Rainin Foundation, Broad Medical Research Program, the Gates Foundation, the Pew Foundation and pharmaceutical companies including Genentech, Pfizer, Janssen and Boehringer-Ingelheim.

Panelist: John G. Dinsmore, Trinity College Dublin, is an Associate Prof. of Digital Health and Integrated Care and Deputy Director of the Trinity Centre for Practice and Healthcare Innovation (TCPHI) at the School of Nursing and Midwifery, Trinity College Dublin. Previously he served on the UK/Ireland Board of Directors for the European Institute of Innovation and Technology Health (2018-22). Dr. Dinsmore's research primarily focuses on the application of health psychology and behavioural science to the design, development, implementation and evaluation of digital health interventions for individuals self-managing chronic diseases and multimorbidity. Dr. Dinsmore has secured significant competitive research funding totalling over €13 million from a variety of international and national award bodies and is coordinator of two European Commission H2020 projects; ProACT ( and SEURO ( His talk will explore the research conducted through these two H2020 projects to advance digital health solutions for multimorbidity management.

Panelist: Julia Liu, Morehouse School of Medicine, graduated from University of Toronto Medical School, received her internal medicine training at Mayo Clinic Rochester and gastroenterology fellowship at Brigham and Women’s Hospital in Boston. She completed a research fellowship at the Harvard Center of Minimally Invasive, and stayed on faculty at Brigham to study the mechanism of endoscopic anti-reflux procedures. She moved to University of Alberta in Edmonton, Canada to establish a robust endoscopy research program. Her research using confocal endomicroscopy quantified and identified cause of leaky gut in patients with inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). She relocated to University of Arkansas for Medical Sciences to translate her research findings into patient care. She recruited to Morehouse School of Medicine to set up a GI fellowship program, and address the disparities in the digestive care of minority underserved patients. At Morehouse, she has set up an active clinical research program, and created the Digestive Research and Education Excellence Aimed at Minorities (DREAM) conference.

Panelist: Guillermo Cecchi, IBM Researchreceived an education in Physics (MSc, University of La Plata, Argentina, 1991), Physics and Biology (PhD, The Rockefeller University, 1994-1999), and Imaging in Psychiatry (Postdoctoral Fellow, Cornell University 2000-2001). He has been interested in diverse aspects of theoretical biology, including Brownian transport, molecular computation, spike reliability in neurons, song production and representation in songbirds, statistics of natural images and visual perception, statistics of natural language, and brain imaging. In 2001 he joined IBM Research to work on computational approaches to brain function.

In recent years, Dr. Cecchi has pioneered the use of a computational linguistics approach to quantify psychiatric conditions from short speech samples, applying it successfully to conditions as diverse as schizophrenia, mania, prodromal psychosis, chronic pain, neurodegeneration, drug and alcohol intake, and psychotherapy. Dr. Cecchi directs the Computational Psychiatry and the Neuroimaging groups in IBM Research, and is Associate Director of Analytics for NIH's Advancing Medicines Partnerships - Schizophrenia.

Session 3: Panel Discusson on Close-loop Therapy and Treatment
July 5, 16:50 - 18:00
Location: Comiskey

Panel Chair & Moderator: Jeffrey L. Rogers, PhD is IBM’s Global Research Leader for Digital Health. Founding the company's efforts at the intersections of artificial intelligence, internet-of-things, and devices applied to healthcare. His work focuses on creating systems of integrated sensors, models, and closed-loop controllers to support personalized health. He has overseen the deployment of these systems to homes, cars, and medical facilities to address applications ranging from managing chronic disease to wellness.

Prior to IBM he held technical leadership positions in industry, government, and academia focused on creating innovative microsystem and healthcare technologies. He was a Director of Engineering at Google where he established a cardiac care portfolio and a DARPA program manager where he developed and fielded tools identifying battlefield brain injuries. While at DARPA he organized the efforts that discovered Topological Insulators and helped establish a health division of the agency, the Biological Technology Office. Prior to joining DARPA he held positions as faculty at California Institute of Technology and as a scientist at HRL Laboratories. He received a Ph.D. in Physics from Georgia Institute of Technology and an M.S. from Emory University.

Dr. Rogers twice received the IBM Eminence and Excellence Award (2020 and 2016). In 2014 he was awarded the Secretary of Defense Medal for Outstanding Public Service and was a Samuel J. Heyman Service to America Medal in Science & Environment finalist. He also received the Joint Meritorious Unit Award in 2012 and an excellence award from the US Special Operations Forces in 2011.

Panelist: Matt McDonald is the director of data research and engineering for the Neuromodulation division of Boston Scientific, has spent nearly his entire career engineering, designing, and planning products with patients and elegant design at the forefront of his thinking.

Currently, Matt is focused on the collaboration with IBM Research to transform the way neuromodulation research is done around the world, with wearables and apps – with the aim to help people with chronic pain live healthier lives. Leveraging his own engineering and design experience, Matt compiled a team with the right clinical, digital, and neuromodulation background to complement IBM’s artificial intelligence work, with the goal of taking a more holistic approach to chronic pain care and creating a monitoring and tracking system based on novel metrics that allow patients to get timely care.

Matt was also a key part of the team that developed the first magnetic research imaging (MRI) conditional spinal cord stimulation systems at Boston Scientific, along with new standards for MRI safety testing. As part of this team, he built out new, robust procedures that helped increase adoption worldwide. He currently holds 60 U.S. patents, is on the internal patent review board, and has received a multitude of honors for his product development and engineering accomplishments. Prior to his roles at Boston Scientific, Matt held other engineering and project management positions at medical device and imaging companies. Matt earned his bachelor’s degree in bioengineering from the University of California, San Diego, and received his master’s degree in mechanical engineering, with a focus on design, from the University of Southern California.

Panelist: Joshua Rosenow, MD is the Director of Functional Neurosurgery and Epilepsy Surgery and Professor of Neurosurgery, Neurology and Physical Medicine and Rehabilitation in the Northwestern University Feinberg School of Medicine Department of Neurosurgery, as well as at Northwestern Memorial Hospital. He specializes in the surgical treatment of movement disorders such as Parkinson’s disease, tremor, and dystonia, as well as the surgical treatment of epilepsy and chronic pain.

He past-President of the Illinois State Neurosurgical Society and has served as Chair of both the AANS/CNS Joint Section on Pain, and the Council of State Neurosurgical Societies. He has been elected to both the Executive Council of the American Society of Stereotactic and Functional Neurosurgery and the Board of Directors of the North American Neuromodulation Society. He is an elected fellow of the American College of Surgeons and a frequent lecturer and instructor at national and international neurosurgical meetings. He is the Co-Chair of the Northwestern Neurology and Neurosurgery Diversity, Equity and Inclusion Committee.

Dr. Rosenow serves organized Neurosurgery as one of the 6 members of the Washington Committee, Chair of the Drugs and Devices Committee, as a delegate to the AMA House of Delegates from the American Association of Neurological Surgeons and as an alternate CPT advisor for Neurosurgery. In addition, he serves as Co-Chair of the North American Neuromodulation Society’s Advocacy and Policy Committee.

Panelist: Douglas J. Weber, PhD is the Akhtar and Bhutta Professor of Mechanical Engineering and Neuroscience at Carnegie Mellon University. Dr. Weber received a Ph.D. in Bioengineering from Arizona State University and completed post-doctoral training in the Centre for Neuroscience at the University of Alberta. His primary research area is Neural Engineering, combining fundamental neuroscience and medical device engineering to understand the neural basis of sensory perception, motor control, and neuroplasticity and drive the development of neurotechnologies for restoring sensorimotor functions in patients. A founding member of DARPA’s Biological Technologies Office, Weber created and managed a portfolio of neurotechnology research programs to support the White House BRAIN initiative, launched by President Obama in 2013. At CMU, he is co-director of the NeuroMechatronics Laboratory, which is a highly multidisciplinary group of students, post-docs and faculty working on projects spanning fundamental and applied studies in animals and translational research in humans. He is also a founder of Reach Neuro, Inc., a medical device startup developing a novel therapy for restoring arm and hand function for people with chronic hemiplegia post-stroke.

Symposium Chairs

Jeff Rogers, IBM Research, Yorktown
Bo Wen, IBM Research, Yorktown

About IEEE

IEEE is the world’s largest professional association advancing innovation and technological excellence for the benefit of humanity. IEEE and its members inspire a global community to innovate for a better tomorrow through its highly cited publications, conferences, technology standards, and professional and educational activities. IEEE is the trusted “voice” for engineering, computing and technology information around the globe.

About IEEE Computer Society

With nearly 85,000 members, the IEEE Computer Society (CS) is the world’s leading organization of computing professionals. Founded in 1946, and the largest of the 38 societies of the Institute of Electrical and Electronics Engineers (IEEE), the CS is dedicated to advancing the theory and application of computer and information-processing technology.

About the Technical Committee on Services Computing

Founded in 2003, IEEE Computer Society’s Technical Community on Services Computing (TCSVC) is a multidisciplinary group whose purpose is to advance and coordinate work in the field of Services Computing carried out throughout the IEEE in scientific, engineering, standard, literary and educational areas. IEEE TCSVC membership details are available at